
Keywords: α-MSH, alpha-melanocyte stimulating hormone; CMHL, combined medial hypothalamic lesion; e-NOS, endothelial nitric oxide synthase; GFAP, glial fibrillary acidic protein; GH, growth hormone; GHD, growth hormone deficient; GHRT, replacement therapy; HIF-1α,